“Taffix® Nasal Powder Spray Forms an Effective Barrier Against Infectious New Variants of SARS-Cov-2 (Alpha, Beta and Delta)” (2021) Archives of Clinical and Biomedical Research, 5(5), pp. 794–802. Available at: https://fortunejournals.org/ojs/index.php/acbr/article/view/14869 (Accessed: 17 September 2026).